Back to Search Start Over

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Invites AstraZeneca (AZN) Investors to Contact Firm, Securities Fraud Case Related to Potential COVID-19 Treatment Filed

Source :
GlobeNewswire. January 28, 2021
Publication Year :
2021

Abstract

SAN FRANCISCO, Jan 28, 2021 (GLOBE NEWSWIRE via COMTEX) -- Hagens Berman urges AstraZeneca PLC (NASDAQ: AZN) investors to submit their losses now. A securities fraud lawsuit has been filed [...]

Subjects

Subjects :
AstraZeneca PLC -- Product development
Securities fraud
Class actions (Civil procedure)
Vaccines -- Product development
Pharmaceutical industry -- Product development
Banking, finance and accounting industries
Business

Details

Language :
English
Database :
Gale General OneFile
Journal :
GlobeNewswire
Publication Type :
News
Accession number :
edsgcl.649913434

Tools

Authors Abstract Subjects Details